Skip to main content

ITRON, INC.

For the period ended Sep 30, 2026. Filed Oct 27, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 27, 2026

ITRI$99.97+1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

(a)No information was required to be disclosed in a report on Form 8-K during the third quarter of 2026 that was not reported.

(b)Not applicable.

(c)Insider Trading Arrangements

Our officers, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934 (the Exchange Act), and directors from time to time enter into contracts, instructions or written plans for the purchase or sale of our securities that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) against liability for trading in securities on the basis of material nonpublic information. During the quarter ended September 30, 2026, the following Section 16 officers adopted, modified, or terminated trading arrangements (as defined in Item 408 of Regulation S-K of the Exchange Act):

On August 14, 2026, David M. Wright, Vice President, Corporate Controller and Chief Accounting Officer, adopted a written trading plan designed to be in effect until February 26, 2027, with respect to the sale of up to 832 shares of Itron, Inc. common stock, subject to certain conditions.

On August 18, 2026, Donald L. Reeves, Senior Vice President, Outcomes, adopted a written trading plan designed to be in effect until August 31, 2027, with respect to the sale of up to 11,616 shares of Itron, Inc. common stock, subject to certain conditions.

On August 24, 2026, Joan S. Hooper, Senior Vice President and Chief Financial Officer, adopted a written trading plan designed to be in effect until June 24, 2027, with respect to the exercise of up to 15,750 stock options of Itron, Inc. common stock, subject to certain conditions.

On September 1, 2026, Justin K. Patrick, Senior Vice President, Device Solutions, adopted a written trading plan designed to be in effect until May 19, 2027, with respect to the sale of up to 7,435 shares of Itron, Inc. common stock, subject to certain conditions.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.